← Leaderboards
Michael Lagunoff
University Of Washington
$11,646,302
Attributed
$11,927,407
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,625,316 · 7
By mechanism
P01$9,448,178 · 2
R01$9,218,864 · 3
T32$562,211 · 1
R21$396,063 · 1
Top collaborators
- Serge Barcy6 shared
- Soren Matthew Gantt6 shared
- Timothy M Rose6 shared
- Jeffrey Vieira6 shared
- Jesse D Bloom2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Nancy Logan Haigwood$37,253,957
- Amritha Subray Bhat$1,889,257
- David W Russell$27,160,623
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellTumorCellsHuman Herpesvirus 8ViralKaposi SarcomaAcquired Immunodeficiency SyndromeEndothelial CellsPathway InteractionsMalignant NeoplasmsCommon NeoplasmGenesHerpesviridae InfectionsLatent InfectionPlayReportingInfectionTherapeutic TargetMaintenanceAfricaEndotheliumVirusHerpesviridaeGene Expression
Grant awards (42)
KSHV immortalization of human lymphatic endothelial cells$428,374
R01 · FY2025 · CA · contact PI
KSHV immortalization of human lymphatic endothelial cells$428,374
R01 · FY2024 · CA · contact PI
KSHV alteration of cellular metabolism$407,928
R01 · FY2024 · CA · contact PI
KSHV alteration of cellular metabolism$408,335
R01 · FY2023 · CA · contact PI
Viral Pathogenesis and Evolution Training Program (VPETP)$286,138
T32 · FY2023 · AI · contact PI
KSHV alteration of cellular metabolism$408,731
R01 · FY2022 · CA · contact PI
KSHV immortalization of human lymphatic endothelial cells$378,440
R01 · FY2022 · CA · contact PI
Viral Pathogenesis and Evolution Training Program (VPETP)$276,073
T32 · FY2022 · AI · contact PI
KSHV alteration of cellular metabolism$409,115
R01 · FY2021 · CA · contact PI
KSHV immortalization of human lymphatic endothelial cells$380,314
R01 · FY2021 · CA · contact PI
KSHV alteration of cellular metabolism$409,487
R01 · FY2020 · CA · contact PI
KSHV immortalization of human lymphatic endothelial cells$382,049
R01 · FY2020 · CA · contact PI
Cellular Requirements for KSHV Latency in Endothelial Cells$178,517
R21 · FY2020 · CA · contact PI
KSHV immortalization of human lymphatic endothelial cells$371,737
R01 · FY2019 · CA · contact PI
KSHV alteration of cellular metabolism$330,675
R01 · FY2019 · CA · contact PI
Cellular Requirements for KSHV Latency in Endothelial Cells$217,546
R21 · FY2019 · CA · contact PI
KSHV immortalization of human lymphatic endothelial cells$359,250
R01 · FY2018 · CA · contact PI
KSHV alteration of cellular metabolism$342,143
R01 · FY2018 · CA · contact PI
KSHV alteration of cellular metabolism$343,260
R01 · FY2017 · CA · contact PI
KSHV alteration of cellular metabolism$344,268
R01 · FY2016 · CA · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,610,585
P01 · FY2015 · DE
KSHV Induction of Angiogenic and Lympliangiogenic Phenotypes$396,362
P01 · FY2015 · DE · contact PI
KSHV alteration of cellular metabolism$345,175
R01 · FY2015 · CA · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,603,989
P01 · FY2014 · DE
KSHV Induction of Angiogenic and Lympliangiogenic Phenotypes$381,805
P01 · FY2014 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,335,154
P01 · FY2013 · DE
KSHV Induction of Angiogenic and Lympliangiogenic Phenotypes$332,482
P01 · FY2013 · DE · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$234,324
P01 · FY2013 · DE
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,406,029
P01 · FY2012 · DE
KSHV Induction of Angiogenic and Lympliangiogenic Phenotypes$348,208
P01 · FY2012 · DE · contact PI
Interactions of KSHV and endothelial cells$261,778
R01 · FY2012 · CA · contact PI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)$1,507,828
P01 · FY2011 · DE
KSHV Induction of Angiogenic and Lympliangiogenic Phenotypes$291,412
P01 · FY2011 · DE · contact PI
Interactions of KSHV and endothelial cells$261,839
R01 · FY2011 · CA · contact PI
Interactions of KSHV and endothelial cells$334,269
R01 · FY2010 · CA · contact PI
Interactions of KSHV and endothelial cells$332,453
R01 · FY2009 · CA · contact PI
Interactions of KSHV and endothelial cells$270,107
R01 · FY2008 · CA · contact PI
Interactions of KSHV and endothelial cells$249,651
R01 · FY2007 · CA · contact PI
Interactions of KSHV and endothelial cells$254,213
R01 · FY2006 · CA · contact PI
Interactions of KSHV and endothelial cells$260,573
R01 · FY2005 · CA
Interactions of KSHV and endothelial cells$258,510
R01 · FY2004 · CA
Interactions of KSHV and endothelial cells$257,816
R01 · FY2003 · CA